Prevalence and treatment of depression in Parkinson's disease

Veazey, Connie, Ozlem Erden Aki, Sahinde, Cook, Karon F., Lai, Eugene C., Kunik, Mark E.·2005·The Journal of Neuropsychiatry and Clinical Neurosciences
DOI 10.1176/jnp.17.3.310

Cited by (162)

Items 101–162 of 162

  1. Exploring Nonmotor Neuropsychiatric Manifestations of Parkinson Disease in a Comprehensive Care Setting
    Amitha Dhingra, A. Umair Janjua, Laura M. Hack, Gabriella Waserstein, Justin M. Palanci, Adriana Patricia Hermida · 2020 · Journal of Geriatric Psychiatry and Neurology
  2. Les troubles anxiodépressifs dans la maladie de Parkinson : une revue de la littérature
    Sébastien Montel, Catherine Bungener · 2007 · Annales Médico-psychologiques revue psychiatrique
  3. Risk Factors of Major Depressive Disorder in Parkinson’s Disease
    Mohammad Ibrahim Khalil, Md Ridwanur Rahman, Serajoom Munira, Mohmood Uz Jahan · 2018 · Bangladesh Medical Research Council Bulletin
  4. Lack of independent mood-enhancing effect for dopaminergic medications in early Parkinson's disease
    Alberto Javier Espay, Eric D. Foster, Christopher S. Coffey, Liz Uribe, Chelsea Caspell‐Garcia, Daniel A. Weintraub · 2019 · Journal of the Neurological Sciences
  5. Neuropsychiatric Treatments for Parkinson's Disease: Nonpharmacological Approaches
    Neha Mathur, Haseel Bhatt, Sarah C. Lidstone · 2022 · Seminars in Neurology
  6. Understanding health care needs among Veterans with Parkinson's disease: A survey study
    Megan P. Feeney, John E. Duda, Amie Hiller, Jay I. Phillips, Christiana Evers, Nicole Yarab, Veronica Todaro, Lydia Rader, Sheera Rosenfeld · 2022 · Frontiers in Neurology
  7. Effect of Different Drugs Influencing Monoamine Neurotransmission on Haloperidol-Induced Catalepsy in Mice
    Omar M. E. Abdel‐Salam, Ayman Ragab Baiuomy · 2007 · DergiPark (Istanbul University)
  8. Screening for non-motor symptoms in Egyptian patients with Parkinson’s disease
    Shaimaa Shaheen Mohammed, Raed Mohamed Ali, Marwa Farghaly, Omar Amin El-Serafy, Mohamed I. Hegazy · 2022 · The Egyptian Journal of Neurology Psychiatry and Neurosurgery
  9. Validity of the DESPAR questionnaire as a new screening tool for depression in Parkinson’s disease
    Alexander Storch, Yvonne Paelecke–Habermann, Christine B. Schneider, Wolfgang H. Jost, G. Fuchs, Per Odin, Gerd Reifschneider, Michael Bauer, Heinz Reichmann, Bernd Leplow et al. · 2011 · Basal Ganglia
  10. Movement disorders: Neurodevelopment and neurobehavioural expression
    T. Archer, Richard J Beninger · 2006 · Journal of Neural Transmission
  11. Behavior and Personality Disturbances
    Carissa R. Gehl, Jane S. Paulsen · 2012 · Elsevier eBooks
  12. Investigating Affective and Motor Improvements with Dance in Parkinson’s Disease
    Sarah R. Ciantar, Karolina A. Bearss, Gabriella Levkov, Rachel J. Bar, Joseph F. X. DeSouza · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  13. The Role of Neurologist in the Assessment and Treatment of Depression
    Emre Kumral, Fatma Ece Bayam · 2020 · Turkish Journal Of Neurology
  14. Toward a New Science of the Clinical Uses of the Arts
    Steven Brown, Jacob Cameirao · 2023 · Open Psychology
  15. Acupuncture for early Parkinson’s disease with mild to moderate depression: a randomized controlled trial protocol with functional MRI
    Hongli Xiao, Ya-Shuo Ren, H. Yang, Zixi Wang, Zhuohao Li, Yuguo Song, Xiaojia Yuan, Xiaopeng Liu, Peng Chen · 2024 · Frontiers in Neurology
  16. Depression in Parkinson’s Disease: An Update
    Jeana L. Benton, Steven P. Wengel, W. J. Burke · 2012 · Humana Press eBooks
  17. Mental Consequences of Stroke
    Luis Ayerbe · 2015 · Springer eBooks
  18. Basic Principles in the Management of Depression in Neurologic Disorders
    Marco Mula · 2012
  19. Anatomy and Physiology of Limbic System Dysfunction in Parkinson's Disease
    Anthony A. Grace · 2011 · Parkinson s Disease
  20. Evaluation of frequency of depression in a subset of population with idiopathic parkinsonism in a tertiary care hospital
    Aijaz Ali, Shafqat Hussain Mahar, Dileep J.S. Kumar, Meraj Fatima, Saira Abbas, Samar Iltaf, Muhammad Sohaib Asghar · 2021 · Romanian Journal of Neurology
  21. Prevalence of depression and receipt of antidepressant pharmacotherapy among patients with Parkinson’s disease: a national assessment of US office-based physician visits
    Nicole K. Early, Alyssa M. Peckham, Kathleen A. Fairman, David Alexander Sclar · 2017 · Journal of Parkinsonism and Restless Legs Syndrome
  22. Pathophysiology of Non-Dopaminergic Monoamine Systems in Parkinson's Disease: Implications for Mood Dysfunction
    Nirmal Bhide, Christopher Bishop · 2011 · InTech eBooks
  23. [Parkinson's disease: psychological and behavioral disorders].
    Daniel Delgadillo, Jean‐Christophe Corvol, Marie-Christine Gély-Nargeot, Lucette Lacomblez · 2006 · PubMed
  24. Cognitive impairment in patients with Parkinson’s disease: profiles and implications for prognosis
    Carmen Cristea Janvin · 2007 · NORA - Norwegian Open Research Archives
  25. Major depression in Parkinson's disease
    Arthur Kümmer, Antônio Lúcio Teixeira · 2009 · Brazilian Journal of Psychiatry
  26. Dépression et maladie de Parkinson
    Umberto Spampinato, François Tison · 2012 · Encyclopédie médico-chirurgicale. Neurologie
  27. Behavior and Personality Disturbances
    Carissa R. Gehl, Jane S. Paulsen · 2008 · Elsevier eBooks
  28. Manifestaciones psiquiátricas en la enfermedad de Parkinson: a propósito de un caso
    es Rodolfo Eduardo Pezoa Jares · 2012
  29. Effect of Antidepressant Fluoxetine A SSRI on Dopamine Dependent Behaviours in Rats
    Kanhaiah More, ana M Thorat, Anjali R. Shinde, Jehangir J. Balsara · 2014 · Research and reviews : journal of pharmacology and toxicological studies
  30. Psychiatric comorbidities in movement disorders
    José Adán Miguel‐Puga, Gabriel Villafuerte, Óscar Arias-Carrión · 2017 · International Review of Psychiatry
  31. Acupuncture- Mediated Activation of the Cholinergic Anti-Inflammatory Pathway- A Review of the Literature
    Eleonora D. Dzoljic · 2017 · Open access Journal of Neurology & Neurosurgery
  32. Factors Influencing Development of Depressive Illness among Parkinson’s Disease Patients
    Provat Kumar Sarkar, Hasan Zahidur Rahman, Mahua Chandra, Anis Ahmed, Md Enayet Ul Islam, Abdul Kader Shaikh, Rashed Imam Zahid, Gurudas Mondal, Abu Nayeem, Afzal Momin · 2019 · Journal of National Institute of Neurosciences Bangladesh
  33. An Investigation of the Cognitive and Psychiatric Profile for People with Parkinson's Disease Without Dementia.
    Audrey McKinlay · 2007
  34. Depressivität und Depression bei der Parkinson-Erkrankung
    Yvonne Paelecke–Habermann, Georg Ebersbach, Bernd Leplow · 2007 · Zeitschrift für Neuropsychologie
  35. Laser Literature Watch
    2006 · Photomedicine and Laser Surgery
  36. Parkinson Disease
    Nutan Sharma · 2008 · Elsevier eBooks
  37. Avaliação do tratamento de depressão em pacientes com doença de Parkinson através de ressonância magnética funcional
    Ellison Fernando Cardoso · 2008
  38. Psychiatric Disorders
    Steven P. Wengel, Roberto F. Cervantes, W. J. Burke · 2018
  39. Depression in Parkinson's disease
    Uwe Ehrt · 2010 · NORA - Norwegian Open Research Archives
  40. Acupunctuur als complementaire behandelwijze bij de ziekte van Parkinson
    J.P. Oosterman · 2007 · Utrecht University Repository (Utrecht University)
  41. Depression in patients with Parkinson's disease: identification and treatment
    D. R. Stuart Jamieson, AE Jamieson · 2007 · British Journal of Hospital Medicine
  42. Depressione e malattia di Parkinson
    Umberto Spampinato, François Tison · 2013 · EMC - Neurologia
  43. Avaliação do tratamento de depressão em pacientes com doença de Parkinson através de ressonância magnética funcional
    Ellison Fernando Cardoso · 2009 · Radiologia Brasileira
  44. The Effects of Acute Tryptophan Depletion on Movement, Mood, and Cognition in Patients with Parkinson’s Disease and Healthy Older Persons
    Janet L. Mace · 2007 · Otago University Research Archive (University of Otago)
  45. A Review of Cognitive and Other Non-Motor Problems in Parkinson’s Disease
    Audrey McKinlay · 2013 · Aging Health
  46. Neuropsychiatric Disorders and Sleep Disturbances in Patients with Parkinson's Disease
    Mohamed E Elwan, NabilR Mohamed, Wafik M El Shaikh, Mohamed Ramadan Soltan · 2010
  47. α-Synuclein aggregation in Parkinson's disease
    Astrid van der Made · 2011
  48. Characterizing the relation between depressive symptoms and Parkinson's disease in a sample of Swedish twins
    Rebecca K. Widoe · 2009
  49. Treatment of depression and anxiety in Parkinson’s Disease
    Lakkhina Troeung · 2013 · eSpace (Curtin University)
  50. A COMPARISON OF THREE DEPRESSION SCALES AS
    Sarah F. Baillon · 2013
  51. Fluoxetine does not impair motor function in patients with Parkinson's disease: correlation between mood and motor functions with plasma concentrations of fluoxetine/norfluoxetine Fluoksetin ne remeti motornu funkciju kod bolesnika sa Parkinsonovom boleš¸ u: korelacija raspoloenja i motorne funkcije sa koncentracijom fluoksetina/norfluoksetina u plazmi
    Vladimir S. Kosti, Zoran Todorovi, Milija Mijajlovi, Marina V. Svetel, Elka D. Stefanova, Igor Petrovi, I. V. kova, Milena Pokrajac · 2012
  52. RESEARCH AND REVIEWS: JOURNAL OF PHARMACOLOGY AND TOXICOLOGICAL STUDIES Effect of Antidepressant Fluoxetine A SSRI on Dopamine Dependent Behaviours in Rats.
    Vandana M Thorat, Anjali R. Shinde, Jehangir J. Balsara · 2014
  53. Chaperone-mediated autophagy: machinery, regulation and biological consequences
    YangZixu Mao, Springer Basel Ag · 2011
  54. Mood & motivation in Parkinson’s disease
    Jennifer S. A. M. Reijnders · 2010
  55. PARKINSON'S DISEASE
    Ludy C. Shih, Daniel Tarsy · 2009 · Elsevier eBooks
  56. Rehabilitation Psychiatry
    Terry Rabinowitz, A. Evan Eyler, John P. Hirdes, Thomas D. Stewart · 2008 · Elsevier eBooks
  57. SINTOMAS DE DEPRESSÃO EM PACIENTES COM DECLÍNIO COGNITIVO LEVE NA DOENÇA DE PARKINSON
    Ana Lara Soares Blum Malak · 2016
  58. Fluoxetine does not Impair Motor Function in Patients with Parkinson’s Disease: Correlation Between Mood and Motor Functions with Plasma Concentrations of Fluoxetine/ Norfluoxetine
    Eleonora D. Dzoljic · 2017 · Journal of Neurology & Stroke
  59. A Comparison of Depression Screening Tools in Parkinson’s Disease and Normal Community Controls Using a Brain and Body Donation Database
    Amanda Rosen · 2012 · UA Campus Repository (The University of Arizona)
  60. A comparison of three depression scales as screening tools for depression in Parkinson's disease
    Sarah F. Baillon · 2013 · Figshare
  61. The Prevalence of Depression in Thai Parkinson's Disease Patients and Their Associated Factors
    Pawut Mekawichai, Surin Saetang · 2014 · Srinagarind Medical Journal (SMJ) - ศรีนครินทร์เวชสาร
  62. Characteristics of Tremorogenesis and Tremorolytic Agents in a Pharmacological Rodent Model of Parkinsonism: Evidence from Behavioral, Neurochemical, and Electrophysiological Studies
    Samantha J. Podurgiel · 2015 · OpenCommons at University of Connecticut (University of Connecticut)